Page 222 - Read Online

HPV-related head and neck cancer. J Neurooncol 2013;112:449-54. 154. Kitamura T, Yogo Y, Ueki T, Murakami S, Aso Y. Presence of human
134. Wood ME, Kelly K, Mullineaux LG, Bunn PA Jr. The inherited papillomavirus type 16 genome in bladder carcinoma in situ of a
nature of lung cancer: a pilot study. Lung Cancer 2000;30:135-44. patient with mild immunodeficiency. Cancer Res 1988;48:7207-11.
135. Matakidou A, Eisen T, Houlston RS. TP53 polymorphisms and lung 155. Gutiérrez J, Jiménez A, de Dios Luna J, Soto MJ, Sorlózano A. Meta-
cancer risk: a systematic review and meta-analysis. Mutagenesis analysis of studies analyzing the relationship between bladder cancer
2003;18:377-85. and infection by human papillomavirus. J Urol 2006;176:2474-81.
136. Syrjänen K. Papillomavirus infections and cancer Papillomaviruses 156. Griffiths TR, Mellon JK. Human papillomavirus and urological
and Human Disease, ed. K Syrjänen, L Gissmann, LG Koss. 1987, tumours: II. Role in bladder, prostate, renal and testicular cancer. BJU
Heidelberg: Springer-Verlag. Int 2000;85:211-7.
137. Syrjänen KJ. Epithelial lesions suggestive of a condylomatous origin 157. Youshya S, Purdie K, Breuer J, Proby C, Sheaf MT, Oliver RT,
found closely associated with invasive bronchial squamous cell Baithun S. Does human papillomavirus play a role in the development
carcinomas. Respiration 1980;40:150-60. of bladder transitional cell carcinoma? A comparison of PCR and
138. Trillo A, Guha A. Solitary condylomatous papillomas of the bronchus. immunohistochemical analysis. J Clin Pathol 2005;58:207-10.
Arch Pathol Lab Med 1988;112:731-3. 158. Lopez-Beltran A, Escudero AL, Vicioso L, Muñoz E, Carrasco JC.
139. Stremlau A, Gissmann L, Ikenberg H, Stark M, Bannasch P, zur Human papillomavirus DNA as a factor determining the survival of
Hausen H. Human papillomavirus type 16 related DNA in an bladder cancer patients. Br J Cancer 1996;73:124-7.
anaplastic carcinoma of the lung. Cancer 1985;55:1737-40. 159. Sano T, Sakurai S, Fukuda T, Nakajima T. Unsuccessful effort to
140. Byrne JC, Tsao MS, Fraser RS, Howley PM. Human papillomavirus-11 detect human papillomavirus DNA in urinary bladder cancers by
DNA in a patient with chronic laryngotracheobronchial papillomatosis the polymerase chain reaction and in situ hybridization. Pathol Int
and metastatic squamous-cell carcinoma of the lung. N Engl J Med 1995;45:506-12.
1987;317:873-8. 160. Li N, Yang L, Zhang Y, Zhao P, Zheng T, Dai M. Human
141. Syrjanen KJ. HPV infections and lung cancer. J Clin Pathol papillomavirus infection and bladder cancer risk: a meta-analysis. J
2002;55:885-91. Infect Dis 2011;204:217-23.
142. Gorgoulis VG, Zacharatos P, Kotsinas A, Kyroudi A, Rassidakis AN, 161. Jimenez-Pacheco A, Exposito-Ruiz M, Arrabal-Polo MA, Lopez-
Ikonomopoulos JA, Barbatis C, Herrington CS, Kittas C. Human Luque AJ. Meta-analysis of studies analyzing the role of human
papillomavirus (HPV) is possibly involved in laryngeal but not in papillomavirus in the development of bladder carcinoma. Korean J
lung carcinogenesis. Human Pathol 1999;30:274-83. Urol 2012;53:240-7.
143. Rezazadeh A, Laber DA, Ghim SJ, Jenson AB, Kloecker G. The role 162. Tenti P, Zappatore R, Romagnoli S, Civardi E, Giunta P, Scelsi R,
of human papilloma virus in lung cancer: a review of the evidence. Stella G, Carnevali L. p53 overexpression and human papillomavirus
Am J Med Sci 2009;338:64-7. infection in transitional cell carcinoma of the urinary bladder:
144. Storey R, Joh J, Kwon A, Jenson AB, Ghim SJ, Kloecker GH. correlation with histological parameters. J Pathol 1996;178:65-70.
Detection of Immunoglobulin G against E7 of Human Papillomavirus 163. Shigehara K, Sasagawa T, Kawaguchi S, Nakashima T, Shimamura
in Non-Small-Cell Lung Cancer. J Oncol 2013;2013:240164. M, Maeda Y, Konaka H, Mizokami A, Koh E, Namiki M. Etiologic
145. Isa SI, Kurahara Y, Yamamoto S, Tamiya A, Omachi N, Asami role of human papillomavirus infection in bladder carcinoma. Cancer
K, Okishio K, Utsumi T, Ito N, Yoon HE, Matsumura A, Atagi S, 2011;117:2067-76.
Kawaguchi T. Molecular analysis of human papillomavirus in never- 164. Moonen PM, Bakkers JM, Kiemeney LA, Schalken JA, Melchers
smokers with non-small cell lung cancer. Oncol Lett 2015;9:927-9. WJ, Witjes JA. Human papilloma virus DNA and p53 mutation
146. Ragin C, Obikoya-Malomo M, Kim S, Chen Z, Flores-Obando R, analysis on bladder washes in relation to clinical outcome of bladder
Gibbs D, Koriyama C, Aguayo F, Koshiol J, Caporaso NE, Carpagnano cancer. Eur Urol 2007;52:464-8.
GE, Ciotti M, Dosaka-Akita H, Fukayama M, Goto A, Spandidos 165. Kamel D, Pääkkö P, Pöllänen R, Vähäkangas K, Lehto VP, Soini
DA, Gorgoulis V, Heideman DA, van Boerdonk RA, Hiroshima K, Y. Human papillomavirus DNA and abnormal p53 expression in
Iwakawa R, Kastrinakis NG, Kinoshita I, Akiba S, Landi MT, Eugene carcinoma of the urinary bladder. APMIS 1995;103:331-8.
Liu H, Wang JL, Mehra R, Khuri FR, Lim WT, Owonikoko TK, 166. Steinestel J, Cronauer MV, Müller J, Al Ghazal A, Skowronek P, Arndt
Ramalingam S, Sarchianaki E, Syrjanen K, Tsao MS, Sykes J, Hee A, Kraft K, Schrader M, Schrader AJ, Steinestel K. Overexpression
SW, Yokota J, Zaravinos A, Taioli E. HPV-associated lung cancers: of p16(INK4a) in urothelial carcinoma in situ is a marker for MAPK-
an international pooled analysis. Carcinogenesis 2014;35:1267-75. mediated epithelial-mesenchymal transition but is not related to
147. Zhai K, Ding J, Shi HZ. HPV and lung cancer risk: a meta-analysis. human papillomavirus infection. PLoS One 2013;8:e65189.
J Clin Virol 2015;63C:84-90. 167. Kim SH, Joung JY, Chung J, Park WS, Lee KH, Seo HK. Detection
148. Hsueh PR. Human papillomavirus, genital warts, and vaccines. J of human papillomavirus infection and p16 immunohistochemistry
Microbiol Immunol Infect 2009;42:101-6. expression in bladder cancer with squamous differentiation. PLoS
149. Derkay CS. Task force on recurrent respiratory papillomas. One 2014;9:e93525.
A preliminary report. Arch Otolaryngol Head Neck Surg 168. Shigehara K, Sasagawa T, Doorbar J, Kawaguchi S, Kobori Y,
1995;121:1386-91. Nakashima T, Shimamura M, Maeda Y, Miyagi T, Kitagawa Y,
150. Omland T, Lie KA, Akre H, Sandlie LE, Jebsen P, Sandvik L, Kadono Y, Konaka H, Mizokami A, Koh E, Namiki M. Etiological
Nymoen DA, Bzhalava D, Dillner J, Brøndbo K. Recurrent role of human papillomavirus infection for inverted papilloma of the
respiratory papillomatosis: HPV genotypes and risk of high-grade bladder. J Med Virol 2011;83:277-85.
laryngeal neoplasia. PLoS One 2014;9:e99114. 169. Shaker OG, Hammam OA, Wishahi MM. Is there a correlation
151. Major T, Szarka K, Sziklai I, Gergely L, Czeglédy J. The between HPV and urinary bladder carcinoma? Biomed Pharmacother
characteristics of human papillomavirus DNA in head and neck 2013;67:183-91.
cancers and papillomas. J Clin Pathol 2005;58:51-5. 170. Alexander RE, Davidson DD, Lopez-Beltran A, Montironi R,
152. Bharti AH, Chotaliya K, Marfatia YS. An update on oral human MacLennan GT, Compérat E, Idrees MT, Emerson RE, Cheng L.
papillomavirus infection. Indian J Sex Transm Dis 2013;34:77-82. Human papillomavirus is not an etiologic agent of urothelial inverted
153. Gallagher TQ, Derkay CS. Pharmacotherapy of recurrent respiratory papillomas. Am J Surg Pathol 2013;37:1223-8.
papillomatosis: an expert opinion. Expert Opin Pharmacother 171. Alexander RE, Davidson DD, Lopez-Beltran A, Montironi R,
2009;10:645-55. MacLennan GT, Compérat E, Idrees MT, Emerson RE, Cheng L. The

212
Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ June 15, 2016 ¦